Sandra Hanks
Overview
Explore the profile of Sandra Hanks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
2409
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Wolf B, Oghabian A, Akinyi M, Hanks S, Tromer E, van Hooff J, et al.
EMBO J
. 2021 May;
40(14):e106536.
PMID: 34009673
Aneuploidy is the leading cause of miscarriage and congenital birth defects, and a hallmark of cancer. Despite this strong association with human disease, the genetic causes of aneuploidy remain largely...
2.
Mahamdallie S, Yost S, Poyastro-Pearson E, Holt E, Zachariou A, Seal S, et al.
Lancet Child Adolesc Health
. 2019 Mar;
3(5):322-331.
PMID: 30885698
Background: Wilms tumour is the most common childhood renal cancer and is genetically heterogeneous. While several Wilms tumour predisposition genes have been identified, there is strong evidence that further predisposition...
3.
Correction: Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height
Tatton-Brown K, Hanks S, Ruark E, Zachariou A, Del Vecchio Duarte S, Ramsay E, et al.
Oncotarget
. 2019 Jan;
9(94):36719.
PMID: 30613354
[This corrects the article DOI: 10.18632/oncotarget.385.].
4.
Ruark E, Renwick A, Clarke M, Snape K, Ramsay E, Elliott A, et al.
F1000Res
. 2018 Sep;
5:386.
PMID: 27158454
To provide a useful community resource for orthogonal assessment of NGS analysis software, we present the ICR142 NGS validation series. The dataset includes high-quality exome sequence data from 142 samples...
5.
Yost S, de Wolf B, Hanks S, Zachariou A, Marcozzi C, Clarke M, et al.
Nat Genet
. 2017 May;
49(7):1148-1151.
PMID: 28553959
Through exome sequencing, we identified six individuals with biallelic loss-of-function mutations in TRIP13. All six developed Wilms tumor. Constitutional mosaic aneuploidies, microcephaly, developmental delay and seizures, which are features of...
6.
Mahamdallie S, Hanks S, Karlin K, Zachariou A, Perdeaux E, Ruark E, et al.
Nat Genet
. 2016 Mar;
48(4):473.
PMID: 27023775
No abstract available.
7.
Ruark E, Munz M, Renwick A, Clarke M, Ramsay E, Hanks S, et al.
F1000Res
. 2016 Feb;
4:883.
PMID: 26834991
To enhance knowledge of gene variation in outbred populations, and to provide a dataset with utility in research and clinical genomics, we performed exome sequencing of 1,000 UK individuals from...
8.
Mahamdallie S, Hanks S, Karlin K, Zachariou A, Perdeaux E, Ruark E, et al.
Nat Genet
. 2015 Nov;
47(12):1471-4.
PMID: 26551668
Wilms tumor is the most common childhood renal cancer. To identify mutations that predispose to Wilms tumor, we are conducting exome sequencing studies. Here we describe 11 different inactivating mutations...
9.
Hanks S, Perdeaux E, Seal S, Ruark E, Mahamdallie S, Murray A, et al.
Nat Commun
. 2014 Aug;
5:4398.
PMID: 25099282
Wilms tumour is a childhood kidney cancer. Here we identify inactivating CTR9 mutations in 3 of 35 Wilms tumour families, through exome and Sanger sequencing. By contrast, no similar mutations...
10.
Tatton-Brown K, Seal S, Ruark E, Harmer J, Ramsay E, Del Vecchio Duarte S, et al.
Nat Genet
. 2014 Mar;
46(4):385-8.
PMID: 24614070
Overgrowth disorders are a heterogeneous group of conditions characterized by increased growth parameters and other variable clinical features such as intellectual disability and facial dysmorphism. To identify new causes of...